Medications are very important part of the treatment regimen when a person is having a disease and wants treatment for that disease. It is a must that an individual must know the possible side effects and adverse effects of medications he is taking to ensure safety is being forwarded at the end of the day. However, the use of certain medications is very crucial because of its content which can put great deal of discomfort to a certain person. Many medical health care professionals and researchers are conducting further studies regarding the safety and effectiveness of these medications. It must be ensured that those patients who are taking these medications should get benefits rather than detriments from the treatment. Recently, another 2 studies regarding medications tackled that the use of chronic bowel disease drugs can actually increase the risk for skin cancer.
Chronic bowel disease is an autoimmune disease which affects the colon. The antibodies of the human body become hyperactive that even the normal cells or the human body cells are being attacked leading to damage of colon cells. Good thing, there are certain medications which can actually treat this disease through immunosuppresion. These medications are called as immunosuppressant drugs which act on the immune system to prevent the hyperactive antibodies from destroying the normal cells of the human body. However, through the use of these medications, skin cancer risks are heightened to a certain extenet.
The new 2 studies were published in the journal Gastroenterology tackled on the immunosuppressant used as a treatment for chronic bowel diseases. The first study was conducted by French researchers led by Dr. Laurent Peyrin-Biroulet, of University Hospital of Nancy. The French researchers found out in their study that the use of immunosuppressant drugs for the treatment of Irritable Bowel Syndrome (IBD) among patients actually showed a significant increased in the risk of developing non-melanoma skin cancer.
The second study which was conducted by Canadian researchers found out that individuals who are having the diseases of chronic bowel disease specifically the Crohn’s disease already possesses the increase risk of developing skin cancer, moreover, the use of immunosuppressant drugs such as the thiopurines can further increase the risk of initiating skin cancer.
Moreover, the authors of the two studies say that the increase in the risk shown for the developing of skin cancer among those individuals who are taking immunosuppressant drugs is only very small. Thus, patients with IBD can still be treated using the said medications.